Medication-info.com Search Menu

Attruby: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
356 mg
Active ingredient:
Similar drugs:

Patient information: uses, side effects, how to take - Attruby

What is ATTRUBY?

ATTRUBY is a prescription medicine used to treat adults with a disease that affects the heart muscle called cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM), to reduce death and hospitalization related to heart problems.

It is not known if ATTRUBY is safe and effective in children.

Before taking ATTRUBY, tell your healthcare provider about all your medical conditions, including if you:

  • are pregnant or plan to become pregnant. It is not known if ATTRUBY will harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with ATTRUBY. You may also report your pregnancy by calling the BridgeBio reporting line at 1-844-550-2246.

  • are breastfeeding or plan to breastfeed. It is not known if ATTRUBY passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with ATTRUBY.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take ATTRUBY?

  • Take ATTRUBY exactly as your healthcare provider tells you to.
  • Take ATTRUBY tablets by mouth 2 times a day, with or without food.

  • Swallow tablets whole. Do not cut, crush, or chew tablets.

What are the possible side effects of ATTRUBY?

The most common side effects of ATTRUBY were mild and include:

  • stomach-area (abdominal) pain
  • diarrhea

These are not all of the possible side effects of ATTRUBY.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store ATTRUBY?

  • Store ATTRUBY tablets at room temperature between 68°F to 77°F (20°C to 25°C).
  • Store in original blister card until use to protect from moisture.

Keep ATTRUBY and all medicines out of the reach of children.

General information about the safe and effective use of ATTRUBY.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use ATTRUBY for a condition for which it was not prescribed. Do not give ATTRUBY to other people, even if they have the same symptoms you have. It may harm them. You can ask your pharmacist or healthcare provider for information about ATTRUBY that is written for health professionals.

What are the ingredients in ATTRUBY?

Active ingredient: acoramidis

Inactive ingredients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and silicon dioxide. The film coating and printing ink contain black iron oxide, glyceryl monocaprylocaprate, hypromellose, polyvinyl alcohol, propylene glycol, talc, titanium dioxide, and vinyl alcohol graft copolymer.

Distributed by: BridgeBio Pharma, Inc., Palo Alto, CA 94304

For more information about ATTRUBY, go to www.ATTRUBY.com or call 1-844-550-2246

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 216540 · View the label on DailyMed

Revision date stated in the text: June 2026

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Attruby

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Transthyretin Stabilizer
Active ingredient Acoramidis hydrochloride 356 mg
Dosage form Tablet, film coated
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) BRIDGEBIO PHARMA
FDA approval NDA 216540New Drug Application (NDA) Approved November 22, 2024
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
356 mg – 28 in 1 blister pack / 1 in 1 dose pack / 4 in 1 carton
356 mg – 120 in 1 bottle / 1 in 1 carton

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.